Evaluation of Diagnostic Performances of 18F-FDOPA PET KInetics
Status:
Not yet recruiting
Trial end date:
2025-10-30
Target enrollment:
Participant gender:
Summary
We hypothesise that 18F-FDOPA PET kinetic parameters are good biomarkers to characterise
suspected LGG brain lesions that exhibit no contrast on MRI, for identifying aggressive
lesions. These parameters could constitute diagnostic biomarkers for this indication. This
new diagnostic tool could enhance patient care in the short term in an evolving pathology
affecting socially active subjects with a poor prognosis